Share Your Perspective: EAHAD Survey on Gene Therapy in Haemophilia Care
European Association for Haemophilia and Allied Disorders (EAHAD) shared an inviting post on LinkedIn:
“Gene therapy brings exciting possibilities for people with haemophilia, but effective care depends on how well healthcare professionals understand, discuss, and integrate it into practice.
We’re conducting a Europe-wide survey to explore current understanding, clinical experience, and decision-making around gene therapy among physicians, nurses, physiotherapists, psychologists, and all professionals involved in haemophilia care.
Your input will help identify educational needs, support better patient communication, and strengthen shared decision-making in clinical practice.”
Your perspective matters, take the survey here.
Stay updated on the emerging with Hemostasis Today.
-
Jan 12, 2026, 04:51Coronary Microvascular Dysfunction and HFpEF․ Prognostic Importance and Therapeutic Insights
-
Jan 12, 2026, 04:16Wolfgang Miesbach on VTE and Cancer: A 20-Year Signal That Can’t Be Ignored
-
Jan 12, 2026, 03:54Francine Freitas Fernandes on Transvaginal US for Pelvic Venous Disorders
-
Jan 12, 2026, 02:58Jara Garcia Ugaldebere Shares STORM-PE Results: Thrombectomy Plus Anticoagulation for Acute High-Risk PE
-
Jan 12, 2026, 02:54Discover the New Blood Project․ Enhanced Search, Browsing, and Learning Resources
-
Jan 12, 2026, 02:54Can Preoperative Iron Status Predict Severe Anemia After Bariatric Surgery?
-
Jan 12, 2026, 02:27Bryce Kerlin to Impact of Advanced Hemostasis/Thrombosis Fellowship Training at Haemophilia Publication
-
Jan 12, 2026, 02:21Martin Haluzík on Compariosn of Cardiovascular Outcomes Between Semaglutide and Dulaglutide Therapies
-
Jan 12, 2026, 01:55Frank Weinz on State-of-the-Art Thromboembolism Prophylaxis